Hey guys, im writing a research paper on steroids for my class, but i found this study on one credible site and i thought it was pretty **** intresting check it out.
Another study tested one of the most powerful and reputedly dangerously toxic anabolic steroids for 30 weeks on HIV positive men and women. Oxymetholone, formerly known as Anadrol in the U.S. and a C-17 alkylated oral steroid, was administered in a dosage of over 1,000 mg per week (more than that used by many bodybuilders, and for a much longer duration of uninterrupted use). The results were significant gains in lean muscle mass--even without any weightlifting. Even more importantly--and surprisingly--there were no significant problems with liver function, water retention, or virilization side effects (it will be interesting to see whether further studies yield consistent findings at such high dosages).
While the dangers of anabolies to athletes' livers appear to have been highly exaggerated, it must be recognized that an apparently healthy athlete with a previously existing but undiscovered liver problem could do serious damage to himself by self-administering C-17 oral anabolic steroids. For this reason alone, it would be quite irresponsible for any athlete to use anabolic steroids without having a physician regularly conduct blood tests to monitor liver function.
i for one found this intresting, becuase i had always thought that anadrol was extremely toxic but this kind of relieved me of that thought. I dont know it just goes to show you what all the media hype can put into someones mind. i got it from a school online resource database.
Source Citation: "The Health Risks of Steroid Use Have Been Exaggerated" by Rick Collins. Performance-Enhancing Drugs James Haley, Ed. At Issue Series. Greenhaven Press, 2003. From "Health Risks of Anabolic Steroids," by Rick Collins, www.steroidlaw.com, 1999. Copyright © 1999 by Rick Collins. Reprinted with permission.
Reproduced in Opposing Viewpoints Resource Center. Farmington Hills, Mich.: Gale Group. 2004http://galenet.galegroup.com/servlet/OVRC